PyInvesting

Market research

AMRH Enveric Biosciences Inc

NASDAQ USD Technology

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
3M
P/E ratio
Not available
Analyst target
0.5
Dividend yield
0.0%
Beta
5.73

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Enveric Biosciences Inc is currently in a long term uptrend where the price is trading 64.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Technology sector with a price to sales ratio of 0.1.

Enveric Biosciences Inc's total revenue sank by 7.3% to $8M since the same quarter in the previous year.

Its net income has increased by 2227.4% to $961K since the same quarter in the previous year.

Finally, its free cash flow fell by 92.7% to $-1M since the same quarter in the previous year.

Based on the above factors, Enveric Biosciences Inc gets an overall score of 3/5.